AbbVie names Robert A. Michael to CEO role (NYSE:ABBV)

Abbvie

vzphotos/iStock Editorial via Getty Images

  • AbbVie (NYSE:ABBV) named Robert A. Michael as the CEO and joined AbbVie’s Board of Directors, effective today.
  • Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company’s inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.
  • Mr. Michael previouslyABBV